-crown-6 ether in toluene. In vitro anticoagulant and
antiplatelet activity of the adduct was studied
Sultanova, .R.M,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Zlotsky, S.S.,
Valiullina, Z.A.,
Karamova, E.V.,
Samorodov, A.V. (2024) The main goal of applying
antiplatelet drugs is a reduced probability of thrombosis so that active
Sultanova, R.M.,
Khusnutdinova, N.S.,
Borisova, Yu. G.,
Raskildina, G.Z.,
Meshcheryakova, S.A.,
Samorodov, A.V.,
Zlotskii, S.S. (2023) . The synthesized 2-substituted 4,5-dihydro-1H-imidazoles were found to possess the
antiplatelet activity
Bogdanov, AV,
Sirazieva, AR,
Voloshina, AD,
Abzalilov, TA,
Abzalilov, TA,
Mironov, VF (2022) -ethylisatins showed the highest
antiplatelet activity which exceeded the activity of acetylsalicylic acid by a
Gurevich, KG,
Urakov, AL,
Rozit, GA,
Klen, EE,
Samorodov, AV,
Khaliullin, FA (2021) confirmed IR and NMR spectroscopic data. The
antiplatelet and anticoagulant activity of the synthesized
KHALIULLIN, F.A.,
KLEN, E.E.,
PAVLOV, V.N.,
SAMORODOV, A.V.,
SHEPILOVA, S.O.,
MAKAROVA, N.N.,
NURLANOVA, S.N.,
ABZALILOV, T.N. (2022)
studies of the
antiplatelet, anticoagulant, and antioxidant activity revealed promising compounds
Spasov, AA,
Kucheryavenko, AF,
Khaliullin, FA,
Gurova, NA,
Sirotenko, VS,
Samorodov, AV,
Gaidukova, KA,
Pavlov, VN (2022) Antithrombotic Activity of the
Antiplatelet Agent Angipur on the Model of Arterial Thrombosis